The tool includes inputs like age, menopausal status, ER, HER2, Ki67 status, invasive tumor size, tumor grade, number of nodes, mode of detection, type of hormonal therapy (HT)/chemotherapy (CT) and provides 5- and 10-year survival estimates as well as treatment benefit predictions [6]. Here, ERBB2 is linked to neoplasm.